help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Harst, E.
Right arrow Articles by Kwekkeboom, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Harst, E.
Right arrow Articles by Kwekkeboom, D. J.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 2 685-693
Copyright © 2001 by The Endocrine Society

Original Studies

[123I]Metaiodobenzylguanidine and [111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas1

Erwin van der Harst, Wouter W. de Herder, Hajo A. Bruining, H. Jaap Bonjer, Ronald R. de Krijger, Steven W. J. Lamberts, Anton H. van de Meiracker, Frans Boomsma, Theo Stijnen, Eric P. Krenning, Fred T. Bosman and Dik J. Kwekkeboom

Departments of Surgery (E.v.d.H., H.A.B., H.J.B.), Internal Medicine III (W.W.d.H., S.W.J.L., A.H.v.d.M., F.B., E.P.K.), Pathology (R.R.d.K.), Biostatistics (T.S.), and Nuclear Medicine (E.P.K., D.J.K.), Erasmus University Hospital, 3000 CA Rotterdam, The Netherlands; and Department of Pathology, University Hospital of Lausanne (F.T.B.), Lausanne, Switzerland

Address all correspondence and requests for reprints to: Erwin van der Harst, M.D., Department of Surgery, Erasmus University Hospital, Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. E-mail: evanderharst{at}hotmail.com

Selecting the appropriate approach for resection and follow-up of pheochromocytomas (PCCs) is highly dependent upon reliable localization and exclusion of multifocal, bilateral, or metastatic disease. Metaiodobenzylguanidine (MIBG) scintigraphy was developed for functional localization of catecholamine-secreting tissues. Somatostatin receptor imaging (SRI) has a high sensitivity for localizing head and neck paragangliomas, but studies of intraabdominal PCCs are rare. In this study we review our experience of [123I]MIBG and SRI, performed since 1983 and 1989, respectively, in the work-up of primary and recurrent PCCs. Scintigraphic results were correlated with catecholamine secretion, size and site, malignancy, associated tumor syndromes, and morphological features.

[123I]MIBG scans were performed in a total of 75 patients, in 70 cases before resection of primary PCCs and in 5 cases because of recurrent disease. Ninety-one PCCs were resected. The overall detection rates were 83.3% and 89.8% for PCCs larger than 1.0 cm. Multifocal disease was detected in 4 patients with [123I]MIBG. [123I]MIBG uptake correlated with greater size of PCC (r = 0.33; P = 0.008) and greater concentration of plasma epinephrine (r = 0.32; P = 0.006). [123I]MIBG-negative PCCs (n = 14) had significantly (P = 0.01) smaller diameters than [123I]MIBG-positive tumors. Furthermore, [123I]MIBG uptake was significantly higher in unilateral (P = 0.02), benign (P = 0.02), sporadic (P = 0.02), intraadrenal (P = 0.02), and capsular invasive (P = 0.03) PCCs than in bilateral, malignant, MEN2A/2B-related, extraadrenal, and noninvasive PCCs, respectively. The detection rate of SRI was only 25% (8 of 32) for primary benign PCCs. In 14 patients metastases occurred, which were effectively visualized with [123I]MIBG in 8 of 14 cases. SRI was able to detect metastases in 7 of 8 cases, including 3 [123I]MIBG-negative metastatic cases. In addition, [123I]MIBG and SRI detected 2 recurrences.

In conclusion, [123I]MIBG uptake is correlated with the size, epinephrine production, and site of PCCs. Its role in bilateral and MEN2A/2B-related PCCs seems limited. In cases of recurrent elevation of catecholamines, localization of metastases and/or recurrence should be attempted with [123I]MIBG scintigraphy. In suspicious metastatic PCCs, SRI might be considered to supplement [123I]MIBG scintigraphy.




This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
H.-B. Fiebrich, A. H. Brouwers, M. N. Kerstens, M. E. J. Pijl, I. P. Kema, J. R. de Jong, P. L. Jager, P. H. Elsinga, R. A. J. O. Dierckx, J. E. van der Wal, et al.
6-[F-18]Fluoro-L-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess
J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3922 - 3930.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. G. Ziegler, J. W. Brown, A. V. Schally, A. Erler, L. Gebauer, A. Treszl, L. Young, L. M. Fishman, J. B. Engel, H. S. Willenberg, et al.
Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: Antiproliferative effects of peptide analogues
PNAS, September 15, 2009; 106(37): 15879 - 15884.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
G. A. Wiseman, K. Pacak, M. S. O'Dorisio, D. R. Neumann, A. D. Waxman, D. A. Mankoff, S. I. Heiba, A. N. Serafini, S. S. Tumeh, N. Khutoryansky, et al.
Usefulness of 123I-MIBG Scintigraphy in the Evaluation of Patients with Known or Suspected Primary or Metastatic Pheochromocytoma or Paraganglioma: Results from a Prospective Multicenter Trial
J. Nucl. Med., September 1, 2009; 50(9): 1448 - 1454.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
B Havekes, A A van der Klaauw, M M Weiss, J C Jansen, A G L van der Mey, A H J T Vriends, B A Bonsing, J A Romijn, and E P M Corssmit
Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas
Endocr. Relat. Cancer, June 1, 2009; 16(2): 527 - 536.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
F. Imani, V. G. Agopian, M. S. Auerbach, M. A. Walter, F. Imani, M. R. Benz, R. A. Dumont, C. K. Lai, J. G. Czernin, and M. W. Yeh
18F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas
J. Nucl. Med., April 1, 2009; 50(4): 513 - 519.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
S. Kauhanen, M. Seppanen, J. Ovaska, H. Minn, J. Bergman, P. Korsoff, P. Salmela, J. Saltevo, T. Sane, M. Valimaki, et al.
The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors
Endocr. Relat. Cancer, March 1, 2009; 16(1): 255 - 265.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
L. Chen, F. Li, H. Zhuang, H. Jing, Y. Du, and Z. Zeng
99mTc-HYNIC-TOC Scintigraphy Is Superior to 131I-MIBG Imaging in the Evaluation of Extraadrenal Pheochromocytoma
J. Nucl. Med., March 1, 2009; 50(3): 397 - 400.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
G. W. L. Boland, M. A. Blake, P. F. Hahn, and W. W. Mayo-Smith
Incidental Adrenal Lesions: Principles, Techniques, and Algorithms for Imaging Characterization
Radiology, December 1, 2008; 249(3): 756 - 775.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
I. Ilias, C. C. Chen, J. A. Carrasquillo, M. Whatley, A. Ling, I. Lazurova, K. T. Adams, S. Perera, and K. Pacak
Comparison of 6-18F-Fluorodopamine PET with 123I-Metaiodobenzylguanidine and 111In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic Pheochromocytoma
J. Nucl. Med., October 1, 2008; 49(10): 1613 - 1619.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
S. Grozinsky-Glasberg, I. Shimon, M. Korbonits, and A. B Grossman
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms
Endocr. Relat. Cancer, September 1, 2008; 15(3): 701 - 720.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
D. Pasquali, V. Rossi, G. Conzo, G. Pannone, P. Bufo, A. De Bellis, A. Renzullo, G. Bellastella, A. Colao, G. Vallone, et al.
Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells
J. Mol. Endocrinol., June 1, 2008; 40(6): 263 - 271.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
T. Zelinka, H. J L M Timmers, A. Kozupa, C. C Chen, J. A Carrasquillo, J. C Reynolds, A. Ling, G. Eisenhofer, I. Lazurova, K. T Adams, et al.
Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations
Endocr. Relat. Cancer, March 1, 2008; 15(1): 311 - 323.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A. Karagiannis, D. P Mikhailidis, V. G Athyros, and F. Harsoulis
Pheochromocytoma: an update on genetics and management
Endocr. Relat. Cancer, December 1, 2007; 14(4): 935 - 956.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
H. J.L.M. Timmers, M. Hadi, J. A. Carrasquillo, C. C. Chen, L. Martiniova, M. Whatley, A. Ling, G. Eisenhofer, K. T. Adams, and K. Pacak
The Effects of Carbidopa on Uptake of 6-18F-Fluoro-L-DOPA in PET of Pheochromocytoma and Extraadrenal Abdominal Paraganglioma
J. Nucl. Med., October 1, 2007; 48(10): 1599 - 1606.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
I. Ilias, A. Sahdev, R. H Reznek, A. B Grossman, and K. Pacak
The optimal imaging of adrenal tumours: a comparison of different methods
Endocr. Relat. Cancer, September 1, 2007; 14(3): 587 - 599.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
C. M. Intenzo, S. Jabbour, H. C. Lin, J. L. Miller, S. M. Kim, D. M. Capuzzi, and E. P. Mitchell
Scintigraphic Imaging of Body Neuroendocrine Tumors
RadioGraphics, September 1, 2007; 27(5): 1355 - 1369.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. J.L.M. Timmers, A. Kozupa, C. C. Chen, J. A. Carrasquillo, A. Ling, G. Eisenhofer, K. T. Adams, D. Solis, J. W.M. Lenders, and K. Pacak
Superiority of Fluorodeoxyglucose Positron Emission Tomography to Other Functional Imaging Techniques in the Evaluation of Metastatic SDHB-Associated Pheochromocytoma and Paraganglioma
J. Clin. Oncol., June 1, 2007; 25(16): 2262 - 2269.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. Korner, M. Stockli, B. Waser, and J. C. Reubi
GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting
J. Nucl. Med., May 1, 2007; 48(5): 736 - 743.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
P. Kaji, J. A Carrasquillo, W M. Linehan, C. C Chen, G. Eisenhofer, P. A Pinto, E. W Lai, and K. Pacak
The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome
Eur. J. Endocrinol., April 1, 2007; 156(4): 483 - 487.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Scholz, G. Eisenhofer, K. Pacak, H. Dralle, and H. Lehnert
Current Treatment of Malignant Pheochromocytoma
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1217 - 1225.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. van Essen, E. P. Krenning, P. P. Kooij, W. H. Bakker, R. A. Feelders, W. W. de Herder, J. G. Wolbers, and D. J. Kwekkeboom
Effects of Therapy with [177Lu-DOTA0, Tyr3]Octreotate in Patients with Paraganglioma, Meningioma, Small Cell Lung Carcinoma, and Melanoma
J. Nucl. Med., October 1, 2006; 47(10): 1599 - 1606.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Ezziddin, T. Logvinski, C. Yong-Hing, H. Ahmadzadehfar, H.-P. Fischer, H. Palmedo, J. Bucerius, M. J. Reinhardt, and H.-J. Biersack
Factors Predicting Tracer Uptake in Somatostatin Receptor and MIBG Scintigraphy of Metastatic Gastroenteropancreatic Neuroendocrine Tumors
J. Nucl. Med., February 1, 2006; 47(2): 223 - 233.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. G. E. H. Lam, C. J. M. Lips, P. L. Jager, R. P. F. Dullaart, E. G. W. M. Lentjes, P. P. van Rijk, and J. M. H. de Klerk
Repeated [131I]Metaiodobenzylguanidine Therapy in Two Patients with Malignant Pheochromocytoma
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5888 - 5895.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. S. Kohane, J. R. Ingelfinger, K. Nimkin, and C.-L. Wu
Case 16-2005 - A Nine-Year-Old Girl with Headaches and Hypertension
N. Engl. J. Med., May 26, 2005; 352(21): 2223 - 2231.
[Full Text] [PDF]

Home page
 RadioGraphicsHome page
M. A. Blake, M. K. Kalra, M. M. Maher, D. V. Sahani, A. T. Sweeney, P. R. Mueller, P. F. Hahn, and G. W. Boland
Pheochromocytoma: An Imaging Chameleon
RadioGraphics, October 1, 2004; 24(suppl_1): S87 - S99.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
G. Eisenhofer, S. R Bornstein, F. M Brouwers, N.-K. V Cheung, P. L Dahia, R. R de Krijger, T. J Giordano, L. A Greene, D. S Goldstein, H. Lehnert, et al.
Malignant pheochromocytoma: current status and initiatives for future progress
Endocr. Relat. Cancer, September 1, 2004; 11(3): 423 - 436.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K. Pacak, G. Eisenhofer, and D. S. Goldstein
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
Endocr. Rev., August 1, 2004; 25(4): 568 - 580.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
G. A. Kaltsas, G. M. Besser, and A. B. Grossman
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
Endocr. Rev., June 1, 2004; 25(3): 458 - 511.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. H. Kann, B. Wirkus, T. Behr, K.-J. Klose, and S. Meyer
Endosonographic Imaging of Benign and Malignant Pheochromocytomas
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1694 - 1697.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. Ilias and K. Pacak
Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 479 - 491.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. M. Manger
In Search of Pheochromocytomas
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4080 - 4082.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. Ilias, J. Yu, J. A. Carrasquillo, C. C. Chen, G. Eisenhofer, M. Whatley, B. McElroy, and K. Pacak
Superiority of 6-[18F]-Fluorodopamine Positron Emission Tomography Versus [131I]-Metaiodobenzylguanidine Scintigraphy in the Localization of Metastatic Pheochromocytoma
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4083 - 4087.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
A.-M. O'Carroll
Localization of Messenger Ribonucleic Acids for Somatostatin Receptor Subtypes (sstr1-5) in the Rat Adrenal Gland
J. Histochem. Cytochem., January 1, 2003; 51(1): 55 - 60.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Pacak, D. S. Goldstein, J. L. Doppman, B. L. Shulkin, R. Udelsman, and G. Eisenhofer
A ""Pheo"" Lurks: Novel Approaches for Locating Occult Pheochromocytoma
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3641 - 3646.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. R. Conlin and W. C. Faquin
Case 13-2001- A 19-Year-Old Man with Bouts of Hypertension and Severe Headaches
N. Engl. J. Med., April 26, 2001; 344(17): 1314 - 1320.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society